Skip to main content

A multicentric, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of COLIRIOBCN070660 administered topically in patients with moderately severe non-proliferative diabetic retinopathy

Open
  • Protocol code: RETISOM
  • EudraCT code: No aplica
  • Research group: Ophtalmology
  • Service: Ophthalmology
  • Principal investigator:  Boixadera Espax, Ana
  • Pathology: Malalties de l’ull i dels seus annexos
  • Phase: Fase III
  • Status: Recruiting volunteers